Real-World Safety and Effectiveness of Evolocumab in Korean Patients with Atherosclerotic Cardiovascular Disease or Familial Hypercholesterolemia: A Post-Marketing Surveillance Study

Abstract Introduction The efficacy and safety of evolocumab have been established in clinical trials. This post-marketing surveillance (PMS) study investigated the real-world safety and effectiveness of evolocumab in patients with atherosclerotic cardiovascular disease (ASCVD) or familial hyperchole...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Donggyu Moon, Seung-Ho Hur, Sang-Rok Lee, Myung Ho Jeong, Kyung Hoon Cho, Osung Kwon, JinSeon Jeong, Ki Dong Yoo, Evolocumab Post-Marketing Surveillance Research Group
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Adis, Springer Healthcare 2025-10-01
Sarja:	Cardiology and Therapy
Aiheet:	Hypercholesterolemia Cholesterol LDL PCSK9 inhibitors Safety Evolocumab
Linkit:	https://doi.org/10.1007/s40119-025-00430-8
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!